India Glycols Limited (INDIAGLYCO) - Net Assets
Based on the latest financial reports, India Glycols Limited (INDIAGLYCO) has net assets worth Rs29.33 Billion INR (≈ $317.17 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Rs65.23 Billion ≈ $705.43 Million USD) and total liabilities (Rs35.90 Billion ≈ $388.26 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check INDIAGLYCO tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Rs29.33 Billion |
| % of Total Assets | 44.96% |
| Annual Growth Rate | 12.63% |
| 5-Year Change | 65.47% |
| 10-Year Change | 289.83% |
| Growth Volatility | 44.74 |
India Glycols Limited - Net Assets Trend (2005–2026)
This chart illustrates how India Glycols Limited's net assets have evolved over time, based on quarterly financial data. See operational self-sufficiency of India Glycols Limited to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for India Glycols Limited (2005–2026)
The table below shows the annual net assets of India Glycols Limited from 2005 to 2026. For live valuation and market cap data, see India Glycols Limited market cap and net worth.
| Year | Net Assets | Change |
|---|---|---|
| 2026-03-31 | Rs29.33 Billion ≈ $317.17 Million |
+30.01% |
| 2025-03-31 | Rs22.56 Billion ≈ $243.96 Million |
+9.99% |
| 2024-03-31 | Rs20.51 Billion ≈ $221.81 Million |
+7.87% |
| 2023-03-31 | Rs19.01 Billion ≈ $205.63 Million |
+7.28% |
| 2022-03-31 | Rs17.72 Billion ≈ $191.68 Million |
+51.68% |
| 2021-03-31 | Rs11.69 Billion ≈ $126.37 Million |
+13.02% |
| 2020-03-31 | Rs10.34 Billion ≈ $111.81 Million |
+7.40% |
| 2019-03-31 | Rs9.63 Billion ≈ $104.10 Million |
+13.90% |
| 2018-03-31 | Rs8.45 Billion ≈ $91.40 Million |
+12.34% |
| 2017-03-31 | Rs7.52 Billion ≈ $81.36 Million |
+195.72% |
| 2016-03-31 | Rs2.54 Billion ≈ $27.51 Million |
-14.36% |
| 2015-03-31 | Rs2.97 Billion ≈ $32.13 Million |
-20.24% |
| 2014-03-31 | Rs3.72 Billion ≈ $40.28 Million |
-30.49% |
| 2013-03-31 | Rs5.36 Billion ≈ $57.95 Million |
+21.28% |
| 2012-03-31 | Rs4.42 Billion ≈ $47.78 Million |
+14.97% |
| 2011-03-31 | Rs3.84 Billion ≈ $41.56 Million |
-0.33% |
| 2010-03-31 | Rs3.86 Billion ≈ $41.70 Million |
+3.55% |
| 2009-03-31 | Rs3.72 Billion ≈ $40.27 Million |
-24.53% |
| 2008-03-31 | Rs4.93 Billion ≈ $53.36 Million |
+55.58% |
| 2007-03-31 | Rs3.17 Billion ≈ $34.29 Million |
+10.35% |
| 2006-03-31 | Rs2.87 Billion ≈ $31.08 Million |
+19.17% |
| 2005-03-31 | Rs2.41 Billion ≈ $26.08 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to India Glycols Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 0.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (March 2026)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | Rs335.10 Million | 1.14% |
| Other Components | Rs28.99 Billion | 98.86% |
| Total Equity | Rs29.33 Billion | 100.00% |
India Glycols Limited Competitors by Market Cap
The table below lists competitors of India Glycols Limited ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Link Mobility Group Holding ASA
OL:LINK
|
$698.62 Million |
|
Chongqing Constr Engineering
SHG:600939
|
$698.76 Million |
|
Brookfield Real Assets Income
NYSE:RA
|
$698.97 Million |
|
Astra Agro Lestari Tbk
JK:AALI
|
$699.23 Million |
|
Time Publishing and Media Co Ltd Class A
SHG:600551
|
$698.51 Million |
|
Shanxi Zhendong Pharmaceutical
SHE:300158
|
$698.44 Million |
|
Dakota Gold Corp.
NYSE MKT:DC
|
$698.29 Million |
|
Quanta Storage
TWO:6188
|
$698.08 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in India Glycols Limited's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2025 to 2026, total equity changed from 22,558,800,000 to 29,327,800,000, a change of 6,769,000,000 (30.0%).
- Net income of 2,927,600,000 contributed positively to equity growth.
- Dividend payments of 753,100,000 reduced retained earnings.
- New share issuances of 4,669,900,000 increased equity.
- Other comprehensive income decreased equity by 1,140,127,000.
- Other factors increased equity by 1,064,727,000.
Equity Change Factors (2025 to 2026)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Rs2.93 Billion | +9.98% |
| Dividends Paid | Rs753.10 Million | -2.57% |
| Share Issuances | Rs4.67 Billion | +15.92% |
| Other Comprehensive Income | Rs-1.14 Billion | -3.89% |
| Other Changes | Rs1.06 Billion | +3.63% |
| Total Change | Rs- | 30.01% |
Book Value vs Market Value Analysis
This analysis compares India Glycols Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.09x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 11.14x to 2.09x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2005-03-31 | Rs86.49 | Rs963.70 | x |
| 2006-03-31 | Rs103.07 | Rs963.70 | x |
| 2007-03-31 | Rs113.73 | Rs963.70 | x |
| 2008-03-31 | Rs176.69 | Rs963.70 | x |
| 2009-03-31 | Rs133.49 | Rs963.70 | x |
| 2010-03-31 | Rs138.23 | Rs963.70 | x |
| 2011-03-31 | Rs137.82 | Rs963.70 | x |
| 2012-03-31 | Rs158.46 | Rs963.70 | x |
| 2013-03-31 | Rs182.09 | Rs963.70 | x |
| 2014-03-31 | Rs120.30 | Rs963.70 | x |
| 2015-03-31 | Rs95.94 | Rs963.70 | x |
| 2016-03-31 | Rs82.17 | Rs963.70 | x |
| 2017-03-31 | Rs242.99 | Rs963.70 | x |
| 2018-03-31 | Rs272.97 | Rs963.70 | x |
| 2019-03-31 | Rs310.91 | Rs963.70 | x |
| 2020-03-31 | Rs333.92 | Rs963.70 | x |
| 2021-03-31 | Rs377.41 | Rs963.70 | x |
| 2022-03-31 | Rs578.75 | Rs963.70 | x |
| 2023-03-31 | Rs614.12 | Rs963.70 | x |
| 2024-03-31 | Rs662.44 | Rs963.70 | x |
| 2025-03-31 | Rs728.57 | Rs963.70 | x |
| 2026-03-31 | Rs460.31 | Rs963.70 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently India Glycols Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 9.98%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 6.95%
- • Asset Turnover: 0.65x
- • Equity Multiplier: 2.22x
- Recent ROE (9.98%) is above the historical average (5.33%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2005 | 32.38% | 14.00% | 0.73x | 3.18x | Rs539.64 Million |
| 2006 | 20.38% | 8.24% | 0.72x | 3.42x | Rs298.40 Million |
| 2007 | 12.95% | 4.65% | 0.74x | 3.78x | Rs93.45 Million |
| 2008 | 36.24% | 13.28% | 0.92x | 2.96x | Rs1.29 Billion |
| 2009 | -29.31% | -10.68% | 0.57x | 4.80x | Rs-1.46 Billion |
| 2010 | 1.56% | 0.50% | 0.58x | 5.37x | Rs-325.31 Million |
| 2011 | -3.89% | -0.77% | 0.81x | 6.29x | Rs-533.74 Million |
| 2012 | 15.26% | 2.49% | 0.87x | 7.05x | Rs232.24 Million |
| 2013 | 17.83% | 2.79% | 1.10x | 5.82x | Rs419.47 Million |
| 2014 | -43.32% | -5.42% | 0.92x | 8.71x | Rs-1.99 Billion |
| 2015 | -29.84% | -3.44% | 0.82x | 10.62x | Rs-1.18 Billion |
| 2016 | -19.31% | -2.11% | 0.78x | 11.78x | Rs-745.66 Million |
| 2017 | 4.66% | 1.40% | 0.72x | 4.64x | Rs-401.89 Million |
| 2018 | 11.42% | 3.21% | 0.88x | 4.05x | Rs120.13 Million |
| 2019 | 13.78% | 4.03% | 0.87x | 3.93x | Rs363.51 Million |
| 2020 | 11.09% | 3.35% | 0.84x | 3.95x | Rs112.69 Million |
| 2021 | 11.26% | 5.74% | 0.56x | 3.53x | Rs147.49 Million |
| 2022 | 18.97% | 11.85% | 0.62x | 2.58x | Rs1.61 Billion |
| 2023 | 6.58% | 4.74% | 0.54x | 2.56x | Rs-650.62 Million |
| 2024 | 8.43% | 5.25% | 0.59x | 2.74x | Rs-321.09 Million |
| 2025 | 10.24% | 6.13% | 0.61x | 2.74x | Rs53.32 Million |
| 2026 | 9.98% | 6.95% | 0.65x | 2.22x | Rs-5.18 Million |
Industry Comparison
This section compares India Glycols Limited's net assets metrics with peer companies in the Chemicals industry.
Industry Context
- Industry: Chemicals
- Average net assets among peers: $11,777,939,056
- Average return on equity (ROE) among peers: 20.61%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| India Glycols Limited (INDIAGLYCO) | Rs29.33 Billion | 32.38% | 1.22x | $698.56 Million |
| Archean Chemical Industries Limited (ACI) | $19.33 Billion | 5.53% | 0.38x | $700.22 Million |
| The Andhra Sugars Limited (ANDHRSUGAR) | $6.35 Billion | 17.21% | 1.15x | $123.89 Million |
| Bhansali Engineering Polymers Limited (BEPL) | $10.02 Billion | 17.96% | 0.10x | $288.13 Million |
| Chemplast Sanmar Limited (CHEMPLASTS) | $2.46 Billion | 7.18% | 2.72x | $384.86 Million |
| DCW Limited (DCW) | $3.75 Billion | 18.05% | 1.78x | $190.02 Million |
| Deepak Fertilizers and Petrochemicals Corporation Limited (DEEPAKFERT) | $62.54 Billion | 14.93% | 1.10x | $2.08 Billion |
| DIAMINES AND CHEMICALS ORD (BSE) (DIAMINESQ) | $210.14 Million | 44.52% | 1.62x | $26.51 Million |
| DMCC SPECIALITY CHEMICALS LIMITED (DMCC) | $1.98 Billion | 3.50% | 1.02x | $67.27 Million |
| Epigral Ltd. (EPIGRAL) | $10.69 Billion | 33.05% | 1.28x | $532.76 Million |
| Foseco India Limited (FOSECOIND) | $451.96 Million | 44.18% | 0.86x | $423.21 Million |
About India Glycols Limited
India Glycols Limited, a green petrochemical company, manufactures and sells industrial chemicals in India. It operates through Bio-based Specialities and Performance Chemicals, Potable Spirits, and Ennature Biopharma segments. The company offers bio mono ethylene, di ethylene, and tri ethylene glycols; ethyl/butyl glycol ethers and acetates, and brake fluids; bio-polymers comprising guar and nat… Read more